ALSE : Summary for ALSERES PHARMA INC COM USD0.01 - Yahoo Finance

U.S. Markets open in 1 hr 7 mins

Alseres Pharmaceuticals, Inc. (ALSE)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
50.000.00 (0.00%)
At close: 11:26AM EST
People also watch
ADLSAMARCAPSKDUSAFFY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close50.00
Open0.00
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume3
Market Cap306.35k
Beta1.93
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Alseres Pharmaceuticals, Inc. – Value Analysis (US OTC:ALSE) : October 23, 2015
    Capital Cubelast year

    Alseres Pharmaceuticals, Inc. – Value Analysis (US OTC:ALSE) : October 23, 2015

    Capitalcube gives Alseres Pharmaceuticals, Inc. a score of 25.Our analysis is based on comparing Alseres Pharmaceuticals, Inc. with the following peers – Threshold Pharmaceuticals, Inc., Cortex Pharmaceuticals, Inc., Navidea Biopharmaceuticals, Inc., IMRIS Inc., Eli Lilly and Company, International Isotopes Inc., Synthetic Biologics, Inc., Fonar Corporation, iCAD, Inc. and General Electric Company (THLD-US, CORX-US, NAVB-US, IMRSQ-US, […] (Read more...) The post Alseres Pharmaceuticals, Inc. – Value Analysis (US OTC:ALSE) : October 23, 2015 appeared first on CapitalCube.

  • We're sorry this is all we were able to find about this topic.